# Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions

> **NCT04835246** · NA · UNKNOWN · sponsor: **Endofotonics Pte Ltd** · enrollment: 185 (estimated)

## Conditions studied

- Gastric Cancer
- Gastric Precancerous Lesion

## Interventions

- **DEVICE:** Spectra IMDx system

## Key facts

- **NCT ID:** NCT04835246
- **Lead sponsor:** Endofotonics Pte Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-07
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 185 (ESTIMATED)
- **Last updated:** 2021-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04835246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04835246, "Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04835246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*